The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients

Supportive Care in Cancer, 01/24/2011

Warmenhoven F et al. – The aim of this study was to determine the validity of the Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in advanced cancer patients.

Methods

  • Patients with advanced metastatic disease, visiting outpatient palliative care department, asked to fill out self-questionnaire containing Beck Depression Inventory (BDI-II) and single screening question “Are you feeling depressed?”
  • Mood section of PRIME-MD used as gold standard

Results

  • 61 patients with advanced metastatic disease eligible to be included in the study
  • Complete data obtained from 46 patients
  • Area under curve of receiver operating characteristics analysis of BDI-II was 0.82
  • Optimal cut-off point of BDI-II was 16 with sensitivity of 90% and specificity of 69%
  • Single screening question showed sensitivity of 50% and specificity of 94%

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List